# Continuous Lornoxicam Infusion for Orthopaedic Surgery

> **NCT01718756** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Mansoura University** · enrollment: 96 (estimated)

## Conditions studied

- Closed Non Comminuted Long Bone Fractures

## Interventions

- **DRUG:** Placebo
- **DRUG:** Continuous infusion
- **DRUG:** Scheduled

## Key facts

- **NCT ID:** NCT01718756
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2013-06
- **Primary completion:** 2021-12
- **Final completion:** 2022-02
- **Target enrollment:** 96 (ESTIMATED)
- **Why stopped:** No enough fund or cases
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718756, "Continuous Lornoxicam Infusion for Orthopaedic Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01718756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*